Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01560936 · ClinicalTrials.gov registry record
Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 50
- Enrollment target
NCT01560936: Completed study, sponsored by Pediatrix.
NCT01560936 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01560936 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the contamination rate of the parents cell phone in a newborn intensive care setting and identify the types of bacteria contaminating the cell phone as well as evaluating the effectiveness of an antimicrobial gel in reducing the transmission of bacteria from the cell phone to the parents hands.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-03 |
What the finished NCT01560936 record still lists
NCT01560936 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01560936 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01560936 about?
NCT01560936 is a clinical study titled "Surveillance Study of Bacterial Contamination of the Parent's Cell Phone in the NICU". The purpose of this study is to determine the contamination rate of the parents cell phone in a newborn intensive care setting and identify the types of bacteria contaminating the cell phone as well as evaluating the effectiveness of an antimicrobial gel in reducing the transmission of bacteria from...
What is the current status of trial NCT01560936?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-06. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT01560936?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia